+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News The Latest Analyst Ratings For Boston Scientific is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Scientific News The Latest Analyst Ratings For Boston Scientific | RobinsPost News & Noticias

Buy Rating for Boston Scientific: Positive Trends and Growth Potential Ahead


Analyst Larry Biegelsen of Wells Fargo maintained a Buy rating on Boston Scientific (BSX – Research Report), retaining the price target ... Read More

Boston Scientific Corporation (BSX) Stock: More Resilient Than It Appears


Boston Scientific Corporation (BSX) stock saw a modest uptick, ending the day at $81.79 which represents a slight increase of $1.12 or 1.39% from the prior close of $80.67. The stock opened at $80.83 ... Read More

Spotlight on Boston Scientific: Analyzing the Surge in Options Activity


An analyst from Citigroup has decided to maintain their Buy rating on Boston Scientific, which currently sits at a price target of $92. Maintaining their stance, an analyst from Barclays continues to ... Read More

The Zacks Analyst Blog Highlights Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards Lifesciences


Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Boston Scientific Corp ... Read More

The Zacks Analyst Blog Highlights Amazon, Boston Scientific, Shopify and Cooper-Standard


Chicago, IL – August 19, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting ... Read More

Boston Scientific's Upside With Cardiology Devices Drives Momentum


Mizuho Securities raised the price target for Boston Scientific Corporation (NYSE ... Consolidation Of Medical Device Outsourcing, Bullish Analyst Projects Mizuho wrote, “Feedback supports ... Read More

Boston Scientific shares positive leadless pacemaker data


Boston Scientific shared positive data from its MODULAR ATP clinical trial investigating the performance of its Empower leadless pacemaker. Read More

Check Out What Whales Are Doing With BSX


In the last month, 5 experts released ratings on this stock with an average target price of $87.0. An analyst from Citigroup ... Stay informed about the latest Boston Scientific options trades ... Read More

The Latest Analyst Ratings For Zoetis


In the latest quarter, 4 analysts provided ratings for Zoetis (NYSE:ZTS), showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings, shedding light ... Read More

The Latest Analyst Ratings for Installed Building Prods


These 5 analysts have an average price target of $133.0 versus the current price of Installed Building Prods at $145.51, implying downside. Below is a summary of how these 5 analysts rated ... Read More

The Latest Analyst Ratings For Guess


Stay up to date on Guess analyst ratings. If you are interested in following small-cap stock news and performance you can start by tracking it here. Get to Know Guess Better Guess? Inc designs ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus